Skip to content

Effect of dhanvantari 101 taila by nasya and karnapooran and bilwapachotyadi taila by shirodhara and indu vati in karnanada w.s.r.tinnitus.

AN OPEN LABELLED RANDOMISED TRIAL ON NASYA AND KARNAPOORAN WITH DHANWANTARI 101 TAILA AND SHIRODHARA WITH BILWAPACHOTYADI TAILA AND INDU VATI IN KARNANADA WITH SPECIAL REFRENCE TO TINNITUS.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055444
Enrollment
30
Registered
2023-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H838- Other specified diseases of innerear Health Condition 2: H839- Unspecified disease of inner ear

Interventions

None listed

Sponsors

National institute of ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having specific signs and symptoms of Karnanada as per Ayurvedic and modern parameters will be registered. 2. Tinnitus due to otological causes like Otosclerosis, Ototoxity induced Tinnitus, Noice Induced Tinnitus associated with Sensory Neural Hearing Loss will be selected. 3. Patients in the age group of 18-70 years.

Exclusion criteria

Exclusion criteria: 1. Patients having any congenital hearing loss or any deformity. 2. Tinnitus due to Systemic causes 3. Perforated Tympanic membrane 4. Psychogenic hearing loss 5. Patient undergone Otological surgery in past. 6. Infectious disease such as measels, meningitis or any TORCH infection Head injury or injury to ear 7. Malignancy

Design outcomes

Primary

MeasureTime frame
1.Patients having specific signs and symptoms of Karnanada as per Ayurvedic and modern parameters will be registered. 2.Tinnitus due to otological causes like Otosclerosis, Ototoxity induced Tinnitus, Noice Induced Tinnitus associat ed with Sensory Neural Hearing Loss will be selected. 3.Patients in the age group of 18-70 years Timepoint: At baseline day after completion of the trial

Secondary

MeasureTime frame
:Change in Improvement in Hearing Loss. :Change in Improvement in Hearing Loss.Timepoint: 8 weeks

Countries

India

Contacts

Public ContactProfShamsa Fiaz

National Institute of Ayurveda

shamsamys@gmail.com8764009846

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026